← Eichor
Condition: Crohn S Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Crohn S Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's
Phase 4 · 20 location(s) · University of Calgary · NCT05928039A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · 85 location(s) · Janssen Research & Development, LLC · NCT05923073Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-medi
Phase N/A · 4 location(s) · Meyer Children's Hospital IRCCS · NCT06862843Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Cro
Phase 3 · 4 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04777656Ustekinumab With Semi-EN vs Exclusive EN for Preoperative Crohn's Disease Optimization.
NA · 1 location(s) · Xiang Gao · NCT06912815Digestive Biobank for Exploring Microbiota-host Interactions
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05704413Development of New Diagnostic Tools in Capsule Endoscopy
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06152289Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Dis
Phase N/A · 1 location(s) · Shanghai 10th People's Hospital · NCT07694674Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Phase N/A · 12 location(s) · TIDHI Innovation Inc. · NCT07245394Effects of Vaping on Post-operative Recurrence of Crohn's Disease
Phase N/A · 1 location(s) · IRCCS Ospedale San Raffaele · NCT06734780Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
Phase N/A · 1 location(s) · Shmuel Kivity, MD · NCT07644117Evaluation of the SMART IBD App in Pediatric IBD
NA · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07195123Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
Phase 2 · 9 location(s) · Rambam Health Care Campus · NCT05599347Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease
Phase 1 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06902987Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07444060Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease.
NA · 16 location(s) · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ul · NCT04330846Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Die
NA · 1 location(s) · University of Alberta · NCT06683105PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
NA · 1 location(s) · Pontificia Universidad Catolica de Chile · NCT06758024Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).
Phase N/A · 1 location(s) · University of Calgary · NCT07246460Safety of Mesentery-embedding Surgery in Patients With Ileocolic Crohn's Disease on Biotherapy
NA · 2 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT06856044TIDHI Mental Health in IBD Patients Study
NA · 1 location(s) · TIDHI Innovation Inc. · NCT07013578InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06059989Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Pe
Phase N/A · 5 location(s) · Alimentiv Inc. · NCT06670638Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT06655415A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Phase 4 · 53 location(s) · Takeda · NCT06045754Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease
Phase N/A · 6 location(s) · Mercy Medical Center · NCT06750731An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintena
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03167437Decoding the Clinical Impact of Host and Microbial Intestinal Proteomic Landscape in Crohn's Disease
Phase N/A · 1 location(s) · Weizmann Institute of Science · NCT06494826A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease an
Phase N/A · 4 location(s) · AbbVie · NCT07421258Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed
Phase 1 · 1 location(s) · University Medical Center Groningen · NCT05725876
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.